• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

17至24月龄儿童中无细胞百日咳组分白喉-破伤风-百日咳(DTP)疫苗与全细胞百日咳组分DTP疫苗的比较,并检测69千道尔顿外膜蛋白抗体。

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.

作者信息

Blumberg D A, Mink C M, Cherry J D, Reisinger K S, Blatter M M, Congeni B L, Dekker C L, Stout M G, Mezzatesta J R, Scott J V

机构信息

Department of Pediatrics, University of California, Los Angeles School of Medicine 90024.

出版信息

J Pediatr. 1990 Jul;117(1 Pt 1):46-51. doi: 10.1016/s0022-3476(05)82442-4.

DOI:10.1016/s0022-3476(05)82442-4
PMID:2196360
Abstract

Healthy 17- to 24-month-old children, previously immunized with three doses of whole-cell diphtheria-tetanus-pertussis (DTP) vaccine, were enrolled in a multi-center double-blind, randomized study comparing a DTP vaccine with an acellular pertussis-component (APDT) and a conventional whole-cell pertussis-component DTP vaccine. Thirty-eight children received APDT vaccine, and 37 children received DTP vaccine. APDT vaccine recipients had significantly less local pain and warmth than DTP vaccine recipients. Antibody responses to lymphocytosis-promoting factor were similar in the two groups. The APDT vaccine recipients had a higher IgG antibody response to filamentous hemagglutinin than the DTP vaccinees had. Equivalent agglutinin responses were seen in the two groups. The APDT vaccine recipients had a significantly better antibody re-enzyme-linked immunosorbent assay, than DTP vaccinees had 1 month and 1 year after immunization. This APDT vaccine was immunogenic and caused fewer local reactions than conventional DTP vaccine when administered as a fourth dose to 17- to 24-month-old children.

摘要

健康的17至24个月大儿童,此前已接种三剂全细胞白喉-破伤风-百日咳(DTP)疫苗,被纳入一项多中心双盲随机研究,该研究比较了一种DTP疫苗与一种无细胞百日咳成分(APDT)疫苗以及一种传统全细胞百日咳成分DTP疫苗。38名儿童接受了APDT疫苗,37名儿童接受了DTP疫苗。APDT疫苗接种者的局部疼痛和发热明显少于DTP疫苗接种者。两组对淋巴细胞增多促进因子的抗体反应相似。APDT疫苗接种者对丝状血凝素的IgG抗体反应高于DTP疫苗接种者。两组的凝集素反应相当。免疫后1个月和1年时,APDT疫苗接种者的抗体再酶联免疫吸附测定结果明显优于DTP疫苗接种者。这种APDT疫苗具有免疫原性,当作为第四剂给17至24个月大的儿童接种时,其引起的局部反应比传统DTP疫苗少。

相似文献

1
Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.17至24月龄儿童中无细胞百日咳组分白喉-破伤风-百日咳(DTP)疫苗与全细胞百日咳组分DTP疫苗的比较,并检测69千道尔顿外膜蛋白抗体。
J Pediatr. 1990 Jul;117(1 Pt 1):46-51. doi: 10.1016/s0022-3476(05)82442-4.
2
Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.无细胞百日咳组分与全细胞百日咳组分白喉-破伤风-百日咳联合疫苗的比较。一项针对4至6岁儿童的多中心双盲研究。
Am J Dis Child. 1990 Jan;144(1):41-5. doi: 10.1001/archpedi.1990.02150250047029.
3
Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group.
J Pediatr. 1991 Aug;119(2):194-204. doi: 10.1016/s0022-3476(05)80727-9.
4
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany.德国婴儿中Lederle/武田无细胞百日咳疫苗与Lederle全细胞百日咳组分白喉-破伤风-百日咳疫苗的对比研究
Vaccine. 1994 Jan;12(1):81-6. doi: 10.1016/0264-410x(94)90014-0.
5
A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children.一项针对18个月大儿童,比较无细胞百日咳组分白喉破伤风联合疫苗与全细胞百日咳组分白喉破伤风联合疫苗的双盲研究。
Am J Dis Child. 1986 Sep;140(9):872-6. doi: 10.1001/archpedi.1986.02140230042025.
6
Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.美国4至6岁儿童使用BIKEN无细胞白喉破伤风类毒素及百日咳疫苗的临床反应和免疫原性
Am J Dis Child. 1992 May;146(5):556-9. doi: 10.1001/archpedi.1992.02160170036012.
7
Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children.无细胞百日咳疫苗与白喉和破伤风类毒素联合接种在17至24月龄儿童中的安全性和免疫原性。
Pediatr Infect Dis J. 1992 Jul;11(7):530-5. doi: 10.1097/00006454-199207000-00005.
8
Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.15至20月龄儿童无细胞(比肯)百日咳疫苗与全细胞百日咳疫苗的安全性和免疫原性比较。
Am J Dis Child. 1993 Mar;147(3):290-4. doi: 10.1001/archpedi.1993.02160270052017.
9
Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children.无细胞(B型)百日咳组分与全细胞百日咳-白喉-破伤风疫苗作为15至24月龄儿童首次加强免疫的比较。
J Pediatr. 1992 Dec;121(6):857-61. doi: 10.1016/s0022-3476(05)80328-2.
10
Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.白喉和破伤风类毒素联合全细胞百日咳疫苗或无细胞百日咳疫苗进行初次免疫,对15至21月龄儿童一剂含基因灭活百日咳毒素的无细胞百日咳疫苗加强免疫安全性和免疫原性的影响。意大利重组无细胞百日咳疫苗研究多中心小组
J Pediatr. 1995 Aug;127(2):238-43. doi: 10.1016/s0022-3476(95)70301-2.

引用本文的文献

1
Acellular vaccines for preventing whooping cough in children.用于预防儿童百日咳的无细胞疫苗。
Cochrane Database Syst Rev. 2014 Sep 17;2014(9):CD001478. doi: 10.1002/14651858.CD001478.pub6.
2
Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.接种过(已致敏)和未接种过(未致敏)百日咳的幼儿对百日咳博德特氏菌抗原的抗体反应模式。
Clin Vaccine Immunol. 2010 May;17(5):741-7. doi: 10.1128/CVI.00469-09. Epub 2010 Mar 24.
3
Acellular pertussis vaccines. Towards an improved safety profile.
无细胞百日咳疫苗。迈向更优的安全性概况。
Drug Saf. 1996 Nov;15(5):311-24. doi: 10.2165/00002018-199615050-00002.
4
Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children. Monovalent Acellular Pertussis Vaccine Study Group.
Eur J Pediatr. 1995 Mar;154(3):209-14. doi: 10.1007/BF01954273.
5
Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis.全细胞百日咳疫苗接种及感染百日咳博德特氏菌后百日咳凝集素的同种型和抗原特异性
Infect Immun. 1994 Mar;62(3):1118-20. doi: 10.1128/iai.62.3.1118-1120.1994.